Bausch Christoph Lawrence 4
4 · SAB Biotherapeutics, Inc. · Filed Feb 23, 2024
Insider Transaction Report
Form 4
Bausch Christoph Lawrence
CHIEF OPERATING OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2024-02-21+140,000→ 140,000 totalExercise: $5.17Exp: 2034-02-21→ Common Stock (140,000 underlying)
Footnotes (2)
- [F1]Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
- [F2]The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter.